We report on the culture of human insulinoma cells derived from a 32-year-old male patient with hyperinsulinism due to an insulinoma of the pancreas. A single-cell suspension was made by passing insulinoma fragments through a fine-gauge stainless-steel mesh. Cluster-forming insulinoma cells resembling pancreatic islets grew in the presence of fibroblasts. The insulinoma cell clusters could be differentiated from fibroblasts by using in situ pan optic staining and specific immunocytochemical staining (anti-human insulin and anti-human insulinoma monoclonal antibody (mAb) D24). mAb D24 was generated using insulinoma cells as antigen for immunization of a Balb/C mouse and cell fusion by the hybridoma cell technique. The anti-insulinoma cell mAb recognized a 32 kDa protein on immunoblot analysis of neuroendocrine tumor cells. D24 mAb also reacted immunohistochemically with normal pancreatic -cells and tumors such as vipoma, gastrinoma and carcinoid.
Introduction
A number of -cell lines have been generated from insulinomas and hyperplastic islets arising in mice that express a transgene encoding the SV-40Tag oncogene under the control of the insulin promoter (Efrat et al. 1988 , D'Ambra et al. 1990 , Miyazaki et al. 1990 , Hamaguchi et al. 1991 , Radvanyi et al. 1993 . Two of these insulinoma cell lines that maintain correct glucose responsiveness have been cloned (Efrat et al. 1993 , Knaack et al. 1994 . Metabolic studies (Fehmann et al. 1994 , Ferber et al. 1994 ) have been performed using animalderived insulinoma cell lines. Because of the lack of human insulinoma cell lines, rat and mouse cell lines have been used as antigens for detection of pancreatic -cell-specific autoantibodies from humans with insulin-dependent diabetes mellitus (Karounos & Thomas 1990 , Thomas et al. 1990) . No human insulinoma cell line is available. For establishment of cDNA libraries, isolated human islets of Langerhans have been used (Permutt et al. 1989 , Rabin et al. 1992 .
In this study we describe an attempt to grow insulinoma cells derived from a benign insulinoma from a young adult. The cells were tested for insulin secretion at glucose concentrations of 5 and 25 mM. Using the insulinoma cells we were able to develop a monoclonal antibody (mAb) that reacted with pancreatic -cells, insulinoma cells and also other neuroendocrine tumors such as vipoma, gastrinoma and carcinoid. We also present evidence that isolated insulinoma cells express neurofilament and undergo neurite extension on incubation with human nerve growth factor (hNGF).
Materials and Methods

Insulinoma tissue
A 32-year-old male patient presented with hyperinsulinism resulting from an insulinoma of 17 mm diameter. This was surgically removed from the lateral part of the pancreas corpus. Individual clusters of tumor cells were surrounded by connective tissue. The tumor did not show any signs of malignancy. Parts of the tumor appeared to extend into the normal pancreatic parenchyma, but the pancreatic margin of the resection was free of tumor. Tumor cells were absent from the conjointly removed lymph node. Immunohistochemical analysis was performed on tissue cryostat sections and revealed positive staining for neuron-specific enolase, chromogranin A and insulin. Negative results were obtained for glucagon, pancreatic peptide, gastrin, serotonin, somatostatin and -subunit of human choriogonadotropin.
Insulinoma cell culture
A part of the tumor was minced and a single-cell suspension was made by passing insulinoma fragments through a fine-gauge stainless-steel mesh. Cells were washed in RPMI medium supplemented with 10% fetal calf serum. A 3 ml sample of insulinoma cell suspension (1 10 6 cells/ml) was seeded on to Costar Petri dishes (5 cm). Two different cell culture media were tested: (1) RPMI 1640 containing 25 mM Hepes buffer, 5 mM glucose and 580 µg/ml -glutamine with the addition of 100 U/ml penicillin and 100 µg/ml streptomycin and supplemented with 10% fetal calf serum and 5% human serum; (2) Dulbecco's modified Eagle's medium (DMEM), 5 mM glucose, 25 mM Hepes with sodium pyruvate with the addition of 100 U/ml penicillin and 100 µg/ml streptomycin and supplemented with 10% fetal calf serum and 5% human serum. After 5 days of incubation at 37 C in 5% CO 2 /humidified air, nonadherent cells were removed and cells adhering to the Petri dish were fed every third day.
Cell harvesting
After removal of tissue culture media, cells were washed twice with RPMI (protein-free) and then incubated with 0·05% trypsin and 0·053 mM EDTA at 37 C for 7 min. When all cells were detached from the plastic dish, the cell suspension was washed twice in tissue culture medium (1) and either seeded again after dilution 1:3 in tissue culture medium (1) or frozen for later use for mouse immunization or hybridoma selection.
Micromanipulation
In order to obtain slow trypsin activity, dishes containing fibroblasts and insulinoma cells were incubated at room temperature. At a stage when cells had started to detach, insulinoma cells could easily be differentiated from fibroblasts because of their cluster morphology and picked out using a micropipette under continuous invertedmicroscope observation. The harvested insulinoma cells were expelled into a second Petri dish containing fresh tissue culture medium only. The separated cells were selected a second time using a new pipette tip again under microscopic observation in order to avoid unwanted fibroblast transfer. Clusters were plated into 24-multiwell dishes for measurement of insulin release. Cells adhered within 24 h.
Phenotype analysis
Immunofluorescence After removal of cell supernatant, adherent cells were washed twice with PBS. The air-dried cell layer was fixed with ice-cold methanol for 10 min. Fixed cells were wetted with PBS and then stained in situ with fluorescein isothiocyanate (FITC)-conjugated sheep anti-human insulin serum (ICN Immunobiologicals, Lisle, Illinois, USA). After staining, dishes were washed with PBS (3 5 min) and a drop of 1% n-propyl gallate (Sigma, St Louis, MO, USA) mounting fluid (8:2 mixture of glycerol and Tris-HCl, pH 8·4) was used to reduce fluorescence photobleaching (Ge et al. 1994) . Specimens were examined under a fluorescence microscope.
Immunocytochemistry Briefly, slides fixed in acetone (5 min) or culture dishes containing fixed cells (fixation procedure described above) were sequentially incubated with primary mouse mAb followed by rabbit anti-mouse immunoglobulin, then with alkaline phosphataseanti-alkaline phosphatase complex (APAAP) and finally with fast red/naphthol ASBI phosphate as the chromogenic substrate. The cell layer was then counterstained in haematoxylin, and a coverslip was applied using Glycergel as mounting medium (Dako, Glostrup, Denmark). GLUT1 expression was detected by using anti-GLUT1 serum followed by affinity-isolated alkaline phosphatase-conjugated swine anti-rabbit immunoglobulin.
Flow cytometry Cells were harvested using trypsin as described above. After being washed with culture medium, D24 mAb or an isotype control was added to cells and incubated for 30 min on ice. After two washes, the samples were incubated with the FITC conjugate of the F(ab )2 fragment of rabbit anti-mouse immunoglobulin (Dako) for 30 min on ice. Cells were then washed twice, resuspended in ice-cold medium containing sodium azide, and analyzed immediately on a Becton Dickinson FACStar Plus flow cytometer using LYSIS II software (Becton Dickinson, Erembodegem, Belgium) to generate logarithmic fluorescence histograms.
Cytospin preparation
Insulinoma cell and fibroblast (5 10 5 /ml) suspensions were obtained from tissue culture harvest or from the initial tissue processing. Aliquots (100 µl) of cell suspension were placed into each well of a Hettich cytocentrifuge and spun on to the slide at 700 r.p.m. for 10 min. All slides were allowed to dry (4-12 h) before fixation and staining.
Insulin secretion of isolated insulinoma cell clusters
Clusters (1-10 per well) of 3-month-grown insulinoma cells were plated into 24-well culture dishes. Insulinoma cells were free of fibroblasts. Assays were performed 14 days after plating. Cells were incubated with fresh medium containing 5 mM glucose 24 h before the secretion assay was started. On the day of the secretion assay, new tissue culture medium (1) containing 5 or 25 mM glucose was added.
Addition of hNGF , pan optic staining and immunocytochemistry for neurofilament expression
Isolated insulinoma clusters were exposed to 1 ng/ml hNGF for 10 days. Cells were then fixed in situ as described above and stained by pan optic staining as described by Romanovsky (Worman 1989) or by the anti-neurofilament mAb (Dako). The anti-neurofilament mAb labels neurons, neuronal processes, peripheral nerve cells and sympathetic ganglion cells. Stimulated and control cells were photographed in the culture dish using a Leitz Aristoplan microscope.
Reagents
hNGF was obtained from Boehringer-Mannheim, Vienna, Austria. RPMI 1640, DMEM and fetal bovine serum were obtained from Gibco, Vienna, Austria. Insulin and amylin were measured by RIA kits (insulin RIA 100) obtained from Pharmacia, Uppsala, Sweden and Peninsula Laboratories, Belmont, CA, USA respectively. The fibroblast-specific mAb FibAS01 (Saalbach et al. 1996) was used for identification of fibroblasts. Anti-GLUT1 serum was obtained from Chemicon, Temecula, CA, USA. Affinity-isolated alkaline phosphatase-conjugated swine anti-rabbit immunoglobulin was purchased from Dako.
Development of the insulinoma cell-specific mAb D24
Mouse mAb D24 was obtained by immunizing a Balb/C mouse with insulinoma cells and fusing the immune mouse spleen cells with the myeloma cell line 63A8·653 using polyethylene glycol 1500 (Sigma Chemical Co.) by standard techniques. Wells were screened for isulinoma cell-specific mAb production by immunocytochemistry using insulinoma cytospin preparations. Positive wells were analysed by using cryosections of post mortem human pancreatic tissue as well. Only hybridomas found to be immunocytochemically positive for both insulinoma cells and human pancreatic islets were processed further.
Selected hybridomas were cloned (one cell per well) into 96-well microcultures containing 1 10 5 spleen cells/well and 10 U/ml interleukin-6 by micromanipulation. The clones were screened again by immunocytochemistry, and the best producers were chosen for bulk growth.
Extraction of cellular antigen and detection by Western blot using the insulinoma cell-specific mAb D24
Insulinoma cells and other control cell lines were solubilized by adding 100 µl lysis buffer containing 100 mM NaCl, 50 mM Tris-HCl, pH 7·4, 10 mM EDTA, 1% Nonidet P40, 0·1% SDS, 100 µM phenylmethylsulphonyl fluoride and 1 mM diisopropyl fluorophosphate to 3 10 6 cells. The vials were immediately snap-frozen in liquid nitrogen. The sample was thawed and centrifuged at 12 000 g for 5 min at 4 C. An aliquot of the clarified supernatant was loaded on to SDSpolyacrylamide gels (12% polyacrylamide) and run under reducing and non-reducing conditions.
Nitrocellulose filters containing whole cell extract from insulinoma cells, HepG2 human hepatoma cells or post mortem human brain extract were obtained from the SDS-polyacrylamide gels run under reducing and nonreducing conditions. Hybridoma supernatant from mAb D24 was used as primary antibody which was followed by monospecific biotinylated goat anti-mouse immunoglobulin G, and an avidin-biotinylated horseradish peroxidase complex (Vectastain ABC Kit, Vector Laboratories, Burlingame, CA, USA) and developed with 4-chloro-1-naphthol (Sigma, Deisenhofen, Germany) and hydrogen peroxide according to the manufacturer's directions.
Results
Insulinoma cell culture
In order to investigate whether insulinoma cells grow in vitro, a fraction of minced tumor cells was incubated under the tissue culture conditions described above. After 6-12 h incubation, a number of insulinoma cells started to adhere to the RPMI culture medium (culture medium (1)). Dead cells were removed after 6 days and cells were re-fed every fourth day. After 10 days, growth of fibroblasts between the adherent insulinoma cell clusters could be observed. In contrast, insulinoma cells did not grow in DMEM cultures (culture medium (2)). Cells from culture medium (1) were subcultured at 1:3 dilution the first time 3 weeks after seeding. By the fourth passage, fibroblasts already represented about half of the cell population. Insulinoma cells grew in clusters of different size mostly in several cell layers (Fig. 1A) . After 77 days of culture, the rate of insulin secretion into the culture supernatant was 723 U/ml per 24 h. The rate of amylin secretion was 32 pg/ml per 24 h. From each passage, some Petri dishes were fixed 24 h after subculture and stained in situ by pan optic staining (Fig. 1A) and by immunocytochemistry using either the fibroblast-specific mAb FibAS01 or the anti-insulinoma mAb D24 (Fig. 2F) . The D24 mAb clearly differentiated fibroblasts from insulinoma cells. Insulinoma cells were much smaller than fibroblasts and had ovoid nuclei (Fig. 1A) . On pan optic staining, insulinoma cells had blue cytoplasm whereas fibroblasts had a large nucleus and pale cytoplasm (Fig. 1A and Fig. 2F ). Cluster formation was unique to insulinoma cells. To ascertain the morphology of insulin-secreting insulinoma cells further, FITC-conjugated sheep antihuman insulin serum was used to localize the insulinproducing insulinoma cells (Fig. 2D) .
When cells were further subcultured for more than 3 months, fibroblast growth was found to be faster than insulinoma cell growth. Insulinoma cell number therefore decreased from subculture to subculture in parallel with decreasing insulin content in the supernatant.
Culture of isolated insulinoma cells in the absence of fibroblasts
In a second attempt to obtain a pure insulinoma cell culture, insulinoma clusters were separated from the Petri dish by micromanipulation as described above. Insulin secretion from the isolated insulinoma cells was measured in the presence of 5 and 25 mM glucose. Insulin release was dependent on cell number but not on glucose concentration (Table 1) as correct glucose responsiveness was not present. To understand the impaired glucose responsiveness further, the original tumor tissue was immunostained for GLUT1 expression, which was positive not only in this insulinoma but also in two further ones used for testing mAb D24 specificity. Isolated insulinoma cell clusters were maintained for 3 months in culture medium (1). During this time, isolated insulinoma cells developed cytoplasmic extensions, which, upon addition of hNGF (1 ng/ml) tended to become neurite-like projections (Fig. 1B) . After 6 days of stimulation, cells started to form distinct processes. Immunocytochemically, neurofilament protein could be detected with a neurofilament-specific mAb in more than 90% of the induced insulinoma cells (data not shown). This was accompanied by detachment of some cells from the original cluster and formation of axon-like projections which maintained contact with the original cluster (Fig.  1B) . Insulin secretion still occurred (20 µU/ml per 24 h per cluster). Individual clusters contained between 30 and 60 insulinoma cells.
Development and specificity of anti-insulinoma mAb D24
As a part of our continuing effort to characterize pancreatic -cell-specific antigens, we generated a novel mAb using human insulinoma cells as immunogen which recognizes a 32 kDa protein in human neuroendocrine tumor cells and pancreatic -cells. This mAb D24 has been successfully utilized for immunoblotting (Fig. 3) and immunocytochemical procedures. Using this mAb, we have been able to demonstrate that a further three human insulinomas ( Fig. 2A) and tumors relating to the neuroendocrine system such as carcinoid (Fig. 2B), vipoma (Fig. 2C) and gastrinoma also express this antigen. The antibody also recognizes pancreatic -cells of post mortem cryostat tissue sections (Fig. 2E) . There was broad variety in staining intensity of different pancreatic islets. Other tissues such as liver, exocrine pancreas, brain, connective tissue, endothelial cells, epithelium of the bile duct and peripheral In order to investigate whether the D24 mAbrecognized protein represents a cell surface expression molecule, flow cytometric analysis of isolated insulinoma cells or insulinoma cells obtained from tissue culture was performed (Fig. 4) . Surface expression of the D24 mAb-reactive protein was observed on insulinoma cells, but not on fibroblasts. After morphological differentiation of insulinoma cells with multiple cytoplasmic projections, D24 mAb staining was still present but decreased in intensity (immunocytochemistry) when compared with that of freshly isolated insulinoma cells (data not shown).
Discussion
In order to obtain an insulin-secreting -cell-resembling cell line as a source of antigen for the development of islet cell-specific mAbs, we attempted to culture benign human insulinoma cells, which has not been previously reported. Insulinoma cells were shown to grow in coculture with fibroblasts at a low rate and could be separated from the fibroblasts. The cultured insulinoma cells were shown to be devoid of any insulin-secretory response to elevated glucose concentration. This finding is in line with abnormal insulin-secretory responses to glucose described for rat- (Praz et al. 1983 ) and mouse- (Miyazaki et al. 1990) derived insulinomas. Such non-physiological insulin secretion in insulinoma cells is due to abnormal expression of glucose transporter (GLUT1) (Boden et al. 1994) . GLUT1 in insulinomas represents a low-K m glucose transporter protein which is not normally present in pancreatic -cells. However, when the GLUT2 gene was transferred into insulinoma cells, low-and high-affinity glucose-stimulated insulin release could be demonstrated (Ferber et al. 1994) .
In order to evaluate the potential of cultured insulinoma cells for further differentiation, hNGF was added to isolated insulinoma cell clusters. Evidence was thereby provided that hNGF is able to induce neurite formation, as previously also shown for the animal insulinoma cell line RINm5F . Although insulinoma cells undergo some morphological changes when isolated from fibroblasts, the neurite extension is caused by NGF. Neurite extension of murine pancreatic insulin cells on dissociation of cells from the pancreatic islets along with neurofilament expression has also been reported (Teitelman 1990) . The demonstration of similar behavior for human insulinoma cells in this study supports the suggestion that human insulinoma cells also share characteristics with neurons. In this context, it is of note that NGF receptors are present in pancreatic -cell lines and that NGF itself can be produced by fibroblasts (Yoshida & Gage 1992) and can exert profound regulatory stimulation in receptor-bearing target cell lines (Greenberg et al. 1985) .
D24 mAb recognizes a molecule that is strongly expressed not only in insulinoma cells but also in tumor cells (carcinoid, vipoma and gastrinoma) as well as being moderately expressed in post mortem human pancreatic islet tissue. The somewhat surprising expression of the D24 mAb-recognized protein in neuroendocrine-derived tumors other than insulinoma can be explained by the observation (Alpert et al. 1988 ) that all four main islet cell types arise from common precursors. The hormonespecific genes of these precursors become activated sequentially during development (Teitelman et al. 1993) . The most primitive islet cells are often found co-expressing two, three or even four islet hormones (Lukinius et al. 1992) . Similarly, animal insulinoma cell Figure 3 Immunoblotting of human insulinoma cells using mAb D24. Human insulinoma cell extract was loaded on to SDS-12% polyacrylamide gels and run under reducing conditions. Separated proteins were transferred to nitrocellulose and detected using D24 mAb following monospecific biotinylated goat anti-mouse immunoglobulin G and avidin-biotinylated peroxidase complex and developed with 4-chloro-1-naphthol.
lines have been found co-expressing several peptide hormones (Madsen et al. 1986 , Philippe et al. 1987 . Therefore it has to be assumed that these different neuroendocrine cells share protein molecules that are involved in hormone packaging, secretion or signal transduction. One of these shared molecules may be the protein recognized by D24 mAb.
In conclusion, we have been able to grow insulinoma cells in co-culture with fibroblasts. These insulinoma cells, which grow in clusters, show inadequate insulin-secretory response to glucose because of their expression of GLUT1. When isolated clusters of insulinoma cells were incubated in the absence of fibroblasts in the presence of hNGF , neurofilament protein transcription and neurite extension were observed. Using the insulinoma cells as an antigen for immunization of Balb/C mice, we have generated a mAb (D24) that specifically recognizes pancreatic -cells and cells derived from gastrointestinal neuroendocrine tumors such as insulinoma, vipoma, gastrinoma and carcinoid. These observations together with earlier findings in animal models support the hypothesis that human pancreatic -cells share properties with neurons and are related to other neuroendocrine cells in the gastrointestinal tract.
